Chemokine receptors and their role in inflammation and infectious diseases.

Chemokines are small peptides that are potent activators and chemoattractants for leukocyte subpopulations and some nonhemopoietic cells. Their actions are mediated by a family of 7-transmembrane G-protein-coupled receptors, the size of which has grown considerably in recent years and now includes 18 members. Chemokine receptor expression on different cell types and their binding and response to specific chemokines are highly variable. Significant advances have been made in understanding the regulation of chemokine receptor expression and the intracellular signaling mechanisms used in bringing about cell activation. Chemokine receptors have also recently been implicated in several disease states including allergy, psoriasis, atherosclerosis, and malaria. However, most fascinating has been the observation that some of these receptors are used by human immunodeficiency virus type 1 in gaining entry into permissive cells. This review will discuss structural and functional aspects of chemokine receptor biology and will consider the roles these receptors play in inflammation and in infectious diseases.

[1]  C Murdoch,et al.  Cxc chemokine receptor expression on human endothelial cells. , 1999, Cytokine.

[2]  Finn,et al.  Functional expression of chemokine receptor CXCR4 on human epithelial cells , 1999, Immunology.

[3]  P. Weber,et al.  Downregulation by tumor necrosis factor-alpha of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein: a potential mechanism of monocyte retention in atherosclerotic lesions. , 1999, Atherosclerosis.

[4]  T. Honjo,et al.  Fractalkine and macrophage‐derived chemokine: T cell‐attracting chemokines expressed in T cell area dendritic cells , 1999, European journal of immunology.

[5]  Á. Zaballos,et al.  Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. , 1999, Journal of immunology.

[6]  D. Kelvin,et al.  Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. , 1999, Blood.

[7]  B. Rollins,et al.  MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. , 1999, The Journal of clinical investigation.

[8]  Joseph Sodroski,et al.  Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry , 1999, Cell.

[9]  T. Waldmann,et al.  IL-15 induces the expression of chemokines and their receptors in T lymphocytes. , 1999, Journal of immunology.

[10]  E. Minshall,et al.  Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. , 1999, The Journal of allergy and clinical immunology.

[11]  E. Miller,et al.  INHIBITION OF GROα-INDUCED HUMAN ENDOTHELIAL CELL PROLIFERATION BY THE α-CHEMOKINE INHIBITOR ANTILEUKINATE , 1999 .

[12]  K. Burnand,et al.  Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. , 1999, The American journal of pathology.

[13]  C. Mackay,et al.  Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. , 1999, Journal of immunology.

[14]  R. Rabin,et al.  CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3α , 1999, The Journal of Immunology.

[15]  J. A. Badwey,et al.  Neutrophils Stimulated with a Variety of Chemoattractants Exhibit Rapid Activation of p21-Activated Kinases (Paks): Separate Signals Are Required for Activation and Inactivation of Paks , 1998, Molecular and Cellular Biology.

[16]  O. Quehenberger,et al.  Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[17]  A. Mantovani,et al.  Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. , 1998, Journal of immunology.

[18]  J. Bernstein,et al.  Polymorphisms in the human CC chemokine receptor-3 gene. , 1998, Biochimica et biophysica acta.

[19]  J. Sodroski,et al.  CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells. , 1998, Cellular immunology.

[20]  D. Patel,et al.  Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow , 1998, The Journal of experimental medicine.

[21]  M. Waterfield,et al.  The CC Chemokine Monocyte Chemotactic Peptide-1 Activates both the Class I p85/p110 Phosphatidylinositol 3-Kinase and the Class II PI3K-C2α* , 1998, The Journal of Biological Chemistry.

[22]  Y. Yamaguchi,et al.  EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. , 1998, Journal of immunology.

[23]  R. Doms,et al.  Influence of the CCR2-V64I Polymorphism on Human Immunodeficiency Virus Type 1 Coreceptor Activity and on Chemokine Receptor Function of CCR2b, CCR3, CCR5, and CXCR4 , 1998, Journal of Virology.

[24]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[25]  R. Bronson,et al.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Boyd,et al.  Identification of C-C Chemokine Receptor 1 (CCR1) as the Monocyte Hemofiltrate C-C Chemokine (HCC)-1 Receptor , 1998, The Journal of experimental medicine.

[27]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[28]  C. Martínez-A,et al.  The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. , 1998, Journal of immunology.

[29]  M. Rocchi,et al.  The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. , 1998, Journal of immunology.

[30]  A. Kapp,et al.  Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils , 1998, European journal of immunology.

[31]  O. Yoshie,et al.  Identification of Single C Motif-1/Lymphotactin Receptor XCR1* , 1998, The Journal of Biological Chemistry.

[32]  M. Reitz,et al.  Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. , 1998, Blood.

[33]  James G. Boyd,et al.  Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 , 1998, The Journal of experimental medicine.

[34]  Kouji Matsushima,et al.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.

[35]  J. Sodroski,et al.  Structural interactions between chemokine receptors, gp120 Env and CD4. , 1998, Seminars in immunology.

[36]  W. Streit,et al.  Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis , 1998, Journal of Neuroimmunology.

[37]  E. Butcher,et al.  6-C-kine (SLC), a Lymphocyte Adhesion-triggering Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor CCR7 , 1998, The Journal of cell biology.

[38]  M. Essex,et al.  CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Bousquet,et al.  Cutting Edge: IL-4 Induces Functional Cell-Surface Expression of CXCR4 on Human T Cells , 1998, The Journal of Immunology.

[40]  B. Kwon,et al.  Characterization of CKβ8 and CKβ8-1: Two Alternatively Spliced Forms of Human β-Chemokine, Chemoattractants for Neutrophils, Monocytes, and Lymphocytes, and Potent Agonists at CC Chemokine Receptor 1 , 1998 .

[41]  A. Sica,et al.  Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. , 1998, Journal of immunology.

[42]  John P. Moore,et al.  Alanine Substitutions of Polar and Nonpolar Residues in the Amino-Terminal Domain of CCR5 Differently Impair Entry of Macrophage- and Dualtropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[43]  A. Roach,et al.  Human vascular smooth muscle cells express receptors for CC chemokines. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[44]  M. Baggiolini,et al.  B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.

[45]  E. Ohlstein,et al.  Chemokine Receptors in Human Endothelial Cells , 1998, The Journal of Biological Chemistry.

[46]  C. Mackay,et al.  Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes , 1998, The Journal of experimental medicine.

[47]  R. Ganju,et al.  Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. , 1998, Blood.

[48]  P. Gray,et al.  Macrophage-derived Chemokine Is a Functional Ligand for the CC Chemokine Receptor 4* , 1998, The Journal of Biological Chemistry.

[49]  R. Terkeltaub,et al.  A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.

[50]  M. Volin,et al.  Chemokine receptor CXCR4 expression in endothelium. , 1998, Biochemical and biophysical research communications.

[51]  R. Doms,et al.  The CC Chemokine I-309 Inhibits CCR8-dependent Infection by Diverse HIV-1 Strains* , 1998, The Journal of Biological Chemistry.

[52]  Simon A. Jones,et al.  Granulocyte chemotactic protein 2 acts via both IL‐ 8 receptors, CXCR1 and CXCR2 , 1998, European journal of immunology.

[53]  R. Nibbs,et al.  Cloning and Characterization of a Novel Promiscuous Human β-Chemokine Receptor D6* , 1997, The Journal of Biological Chemistry.

[54]  C. Mackay,et al.  Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells , 1997, European journal of immunology.

[55]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[56]  B. Rollins,et al.  Tissue Factor Is Induced by Monocyte Chemoattractant Protein-1 in Human Aortic Smooth Muscle and THP-1 Cells* , 1997, The Journal of Biological Chemistry.

[57]  C. Mackay,et al.  Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils , 1997, Current Biology.

[58]  D. Steiner,et al.  Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. , 1997, DNA and cell biology.

[59]  T. Mcclanahan,et al.  CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells , 1997, The Journal of experimental medicine.

[60]  C. Mackay,et al.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.

[61]  R. Doms,et al.  Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. , 1997, Virology.

[62]  N. Copeland,et al.  TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. , 1997, Immunity.

[63]  M. Baggiolini,et al.  Identification of CCR8, the Receptor for the Human CC Chemokine I-309* , 1997, The Journal of Biological Chemistry.

[64]  M. Metzker,et al.  The extent of genetic variation in the CCR5 gene , 1997, Nature Genetics.

[65]  M. Baggiolini,et al.  Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes , 1997, The Journal of experimental medicine.

[66]  H. Nomiyama,et al.  Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC* , 1997, The Journal of Biological Chemistry.

[67]  O. Yoshie,et al.  The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4* , 1997, The Journal of Biological Chemistry.

[68]  H. Nomiyama,et al.  Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.

[69]  W. Gong,et al.  Monocyte Chemotactic Protein-2 (MCP-2) Uses CCR1 AND CCR2B as Its Functional Receptors* , 1997, The Journal of Biological Chemistry.

[70]  S. Peiper,et al.  From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. , 1997, Blood.

[71]  Deborah Fass,et al.  Core Structure of gp41 from the HIV Envelope Glycoprotein , 1997, Cell.

[72]  A. Sica,et al.  Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes , 1997, The Journal of experimental medicine.

[73]  B. Bennetts,et al.  HIV-1 infection in an individual homozygous for the CCR5 deletion allele , 1997, Nature Medicine.

[74]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[75]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[76]  M. Elkjaer,et al.  Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. , 1997, Blood.

[77]  M. Parmentier,et al.  Molecular cloning and chromosomal mapping of a novel human gene, ChemR1, expressed in T lymphocytes and polymorphonuclear cells and encoding a putative chemokine receptor , 1996, European journal of immunology.

[78]  Mantovani Alberto,et al.  Migratory response of human natural killer cells to lymphotactin , 1996, European journal of immunology.

[79]  R. Doms,et al.  CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 , 1996, Cell.

[80]  Joseph Sodroski,et al.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.

[81]  Á. Zaballos,et al.  Molecular cloning and RNA expression of two new human chemokine receptor-like genes. , 1996, Biochemical and biophysical research communications.

[82]  M. Rocchi,et al.  Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues. , 1996, Journal of immunology.

[83]  T. Yue,et al.  Interferon-inducible Protein-10 Involves Vascular Smooth Muscle Cell Migration, Proliferation, and Inflammatory Response* , 1996, The Journal of Biological Chemistry.

[84]  T. Schall,et al.  RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells , 1996, The Journal of experimental medicine.

[85]  Simon A. Jones,et al.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.

[86]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[87]  Bernhard Moser,et al.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.

[88]  P. Murphy,et al.  The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor* , 1996, The Journal of Biological Chemistry.

[89]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[90]  S. Nishikawa,et al.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 , 1996, Nature.

[91]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[92]  M. Baggiolini,et al.  Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.

[93]  P. Gray,et al.  Molecular Cloning and Functional Characterization of a Novel Human CC Chemokine Receptor (CCR5) for RANTES, MIP-1β, and MIP-1α* , 1996, The Journal of Biological Chemistry.

[94]  Marc Parmentier,et al.  A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.

[95]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[96]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[97]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[98]  P. Murphy.  Chemokine receptors: structure, function and role in microbial pathogenesis. , 1996, Cytokine & growth factor reviews.

[99]  Hirohito Kita,et al.  Chemokines active on eosinophils: potential roles in allergic inflammation , 1996, The Journal of experimental medicine.

[100]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[101]  J. Demartino,et al.  Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.

[102]  C. Combadière,et al.  Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3 (*) , 1996, The Journal of Biological Chemistry.

[103]  G Vassart,et al.  Molecular cloning and functional expression of a new human CC-chemokine receptor gene. , 1996, Biochemistry.

[104]  Huiping Jiang,et al.  Selective G Protein Coupling by C-C Chemokine Receptors (*) , 1996, The Journal of Biological Chemistry.

[105]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.

[106]  R. Strieter,et al.  The role of chemokines in inflammatory joint disease , 1996, Journal of leukocyte biology.

[107]  T. Standiford,et al.  Expression and regulation of chemokines in bacterial pneumonia , 1996, Journal of leukocyte biology.

[108]  R. Strieter,et al.  Activation and regulation of chemokines in allergic airway inflammation , 1996, Journal of leukocyte biology.

[109]  M. Sticherling,et al.  Role of eosinophil‐chemotactic C‐C chemokines in cutaneous inflammation , 1996, Journal of leukocyte biology.

[110]  Zhaohua Lu,et al.  The Duffy antigen receptor for chemokines: structural analysis and expression in the brain , 1996, Journal of leukocyte biology.

[111]  J. Van Damme,et al.  Monocyte Chemoattractant Protein-3 Is a Functional Ligand for CC Chemokine Receptors 1 and 2B (*) , 1995, The Journal of Biological Chemistry.

[112]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[113]  D. Taub,et al.  Granulocyte-Colony Stimulating Factor and Lipopolysaccharide Regulate the Expression of Interleukin 8 Receptors on Polymorphonuclear Leukocytes (*) , 1995, The Journal of Biological Chemistry.

[114]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[115]  R. Rabin,et al.  Human Mig chemokine: biochemical and functional characterization , 1995, The Journal of experimental medicine.

[116]  T. Schall,et al.  Chemokine Class Differences in Binding to the Duffy Antigen-Erythrocyte Chemokine Receptor (*) , 1995, The Journal of Biological Chemistry.

[117]  P. Young,et al.  Monocyte Chemotactic Protein-3 (MCP3) Interacts with Multiple Leukocyte Receptors , 1995, The Journal of Biological Chemistry.

[118]  G. Bokoch.  Chemoattractant signaling and leukocyte activation. , 1995, Blood.

[119]  C. Power,et al.  Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA from a Human Basophilic Cell Line (*) , 1995, The Journal of Biological Chemistry.

[120]  T. Schall,et al.  Molecular cloning and functional characterization of human lymphotactin. , 1995, Journal of immunology.

[121]  S. Manna,et al.  Upregulation of interleukin‐8 receptor in human polymorphonuclear neutrophils by formyl peptide and lipopolysaccharide , 1995, FEBS letters.

[122]  C. Tournamille,et al.  Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals , 1995, Nature Genetics.

[123]  J. Pober,et al.  IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. , 1995, Cytokine.

[124]  H. Flad,et al.  IL-8 specifically binds to endothelial but not to smooth muscle cells. , 1995, Journal of immunology.

[125]  A. Thomson,et al.  IL‐8/IL‐8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy , 1995, Clinical and experimental immunology.

[126]  A. Chuntharapai,et al.  Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. , 1994, Journal of immunology.

[127]  P. Murphy,et al.  Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.

[128]  J. Singh,et al.  Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression , 1994, The Journal of cell biology.

[129]  R. Horuk,et al.  Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. , 1994, The Journal of clinical investigation.

[130]  Y. Tokuda,et al.  cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor. , 1994, Biochemical and biophysical research communications.

[131]  T. Yue,et al.  Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. , 1994, Circulation research.

[132]  F. Finkelman,et al.  Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. , 1994, American journal of respiratory cell and molecular biology.

[133]  S. Coughlin,et al.  Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[134]  S. Watson,et al.  The G-Protein Linked Receptor Facts Book , 1994 .

[135]  A. Minty,et al.  Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine , 1994, The Journal of experimental medicine.

[136]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[137]  T. Geiser,et al.  Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. , 1994, The Journal of biological chemistry.

[138]  K. Williams,et al.  Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[139]  R U Peter,et al.  Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. , 1993, Journal of immunology.

[140]  C. Chitnis,et al.  A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.

[141]  Melvin I. Simon,et al.  G protein-coupled signal transduction pathways for interleukin-8. , 1993, Science.

[142]  T. Schall,et al.  Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. , 1993, The Journal of biological chemistry.

[143]  D. Taub,et al.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells , 1993, The Journal of experimental medicine.

[144]  E. Kieff,et al.  Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.

[145]  H. Rosen,et al.  Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1 , 1993, The Journal of experimental medicine.

[146]  T. Schall,et al.  Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor , 1993, Cell.

[147]  A. Rot.  Neutrophil attractant/activation protein‐1 (interleukin‐8) induces in vitro neutrophil migration by haptotactic mechanism , 1993, European journal of immunology.

[148]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[149]  T. Dobner,et al.  Differentiation‐specific expression of a novel G protein‐coupled receptor from Burkitt's lymphoma , 1992, European journal of immunology.

[150]  A. Haslberger,et al.  Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation. , 1992, The Journal of investigative dermatology.

[151]  W. Wood,et al.  Characterization of two high affinity human interleukin-8 receptors. , 1992, The Journal of biological chemistry.

[152]  L. Kemény,et al.  Interleukin‐8 receptor‐mediated chemotaxis of normal human epidermal cells , 1992, FEBS letters.

[153]  M. Krangel,et al.  The human cytokine I-309 is a monocyte chemoattractant. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[154]  S. Coughlin,et al.  Monocyte chemoattractant protein-1 in human atheromatous plaques. , 1991, The Journal of clinical investigation.

[155]  A. J. Valente,et al.  Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. , 1991, The Journal of clinical investigation.

[156]  P. Murphy,et al.  Cloning of complementary DNA encoding a functional human interleukin-8 receptor. , 1991, Science.

[157]  W I Wood,et al.  Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.

[158]  M. Baggiolini,et al.  Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. , 1991, The Journal of biological chemistry.

[159]  T. Springer,et al.  Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins , 1991, Cell.

[160]  E. Leonard,et al.  Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. , 1990, Journal of immunology.

[161]  C. Homon,et al.  Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. , 1990, The Journal of biological chemistry.

[162]  B. Barrell,et al.  Human cytomegalovirus encodes three G protein-coupled receptor homologues , 1990, Nature.

[163]  G. Gray,et al.  Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. , 1990, Science.

[164]  A. K. Samanta,et al.  Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. , 1990, The Journal of biological chemistry.

[165]  J. Besemer,et al.  Specific binding, internalization, and degradation of human neutrophil activating factor by human polymorphonuclear leukocytes. , 1989, The Journal of biological chemistry.

[166]  P. Rubinstein,et al.  Purification and characterization of an erythrocyte membrane protein complex carrying Duffy blood group antigenicity. Possible receptor for Plasmodium vivax and Plasmodium knowlesi malaria parasite. , 1989, The Journal of biological chemistry.

[167]  J. Barnwell,et al.  In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax , 1989, The Journal of experimental medicine.

[168]  B. Dewald,et al.  A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.

[169]  J. Barnwell,et al.  A new human Duffy blood group specificity defined by a murine monoclonal antibody. Immunogenetics and association with susceptibility to Plasmodium vivax , 1987, The Journal of experimental medicine.

[170]  D. Moscatelli,et al.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.

[171]  E. Goetzl,et al.  Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. , 1982, Journal of immunology.

[172]  J. Dvorak,et al.  Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. , 1975, Science.

[173]  S. Wahl,et al.  N-formylmethionyl peptides as chemoattractants for leucocytes. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[174]  Marsh Wl.  Present status of the Duffy blood group system. , 1975 .

[175]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[176]  E. Miller,et al.  Inhibition of GROalpha-induced human endothelial cell proliferation by the alpha-chemokine inhibitor antileukinate. , 1999, Cytokine.

[177]  A. Kay,et al.  Increased mature and immature CCR3 messenger RNA+ eosinophils in bone marrow from patients with atopic asthma compared with atopic and nonatopic control subjects. , 1999, The Journal of allergy and clinical immunology.

[178]  R. Rabin,et al.  CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. , 1999, Journal of immunology.

[179]  S. Kunkel,et al.  Chemokines and their role in disease , 1998, International journal of clinical & laboratory research.

[180]  B. Kwon,et al.  Characterization of CKbeta8 and CKbeta8-1: two alternatively spliced forms of human beta-chemokine, chemoattractants for neutrophils, monocytes, and lymphocytes, and potent agonists at CC chemokine receptor 1. , 1998, Blood.

[181]  J. Bousquet,et al.  IL-4 induces functional cell-surface expression of CXCR4 on human T cells. , 1998, Journal of immunology.

[182]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[183]  T. Williams,et al.  Animal models of asthma: role of chemokines. , 1997, Methods in enzymology.

[184]  C. Broder,et al.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. , 1996, Science.

[185]  P. Murphy,et al.  The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. , 1996, The Journal of biological chemistry.

[186]  T. Omi,et al.  Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. , 1995, Blood.

[187]  H. Heng,et al.  Isolation of three novel human genes encoding G protein-coupled receptors. , 1995, DNA and cell biology.

[188]  R. Ross,et al.  Cell biology of atherosclerosis. , 1995, Annual review of physiology.

[189]  S. Arya,et al.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.

[190]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[191]  C. Gerard,et al.  C5A anaphylatoxin and its seven transmembrane-segment receptor. , 1994, Annual review of immunology.

[192]  P. Murphy.  The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[193]  D. Adams,et al.  Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. , 1993, Immunology today.

[194]  C. Corrigan,et al.  Asthma. Eosinophils and neutrophils. , 1992, British medical bulletin.

[195]  Kay Ab,et al.  Asthma. Eosinophils and neutrophils. , 1992 .

[196]  D. Hanahan.  Platelet activating factor: a biologically active phosphoglyceride. , 1986, Annual review of biochemistry.

[197]  C. Corrigan,et al.  Eosinophils and neutrophils , 1984 .

[198]  W. Marsh.  Present status of the Duffy blood group system. , 1975, CRC critical reviews in clinical laboratory sciences.

[199]  T. Bonner,et al.  Brief Definitive Report Identification of CCR8: A Human Monocyte and Thymus Receptor for the CC Chemokine I-309 , 2022 .

[200]  K. Matsushima,et al.  Brief Definitive Report Identification and Characterization of Specific Receptors for Monocyte-derived Neutrophil Chemotactic Factor (mdncf) on Human Neutrophils , 2022 .